|
0.5ml Yellow Top Gel and Clot Activator Sst Blood Collection Microtubes
The shift toward pediatric and point-of-care testing is driving demand for miniaturized blood collection systems that maintain full analytical integrity.
China’s contract manufacturing sector has quietly standardized the production of low-volume serum separation tubes, turning a niche clinical tool into a commodity-grade component of global lab supply chains. JUNYUEMED’s NBM03RC exemplifies this: a 0.5ml polypropylene microtube with a yellow cap encoding its function as a serum separator.
The design relies on two integrated additives—an inert barrier gel and a micronized silica clot activator—that accelerate coagulation and form a stable separation layer during centrifugation. This eliminates analyte contamination and maximizes serum yield from samples as small as 0.25ml.
Sterilized via ethylene oxide and certified under CE (IVD) and ISO 13485, the tube meets international safety standards for clinical chemistry and serology workflows. Its 8×44 mm dimensions fit standard micro-centrifuge rotors, minimizing equipment retooling for labs adopting low-volume protocols.
The real industrial story lies in scale and customization. With a monthly output exceeding three million units, JUNYUEMED offers OEM services—private labeling, bespoke packaging, and tailored volume specs—that allow global distributors to brand the same underlying platform.
This reflects a broader shift: China’s medical device manufacturers now compete not on novelty but on production efficiency and regulatory compliance. The NBM03RC is a standardized building block, not a breakthrough—but its availability enables decentralized diagnostics across under-resourced settings.
The infrastructure that matters here is invisible: consistent sterilization lines, validated barrier gels, and packaging that survives global freight. The tube itself is merely the interface.
For procurement managers, the takeaway is straightforward: specification-matched microtubes from ISO-certified Chinese facilities now offer price-competitive alternatives to legacy European suppliers, without sacrificing traceability.
Why it matters:
This microtube represents the commoditization of precision blood collection—where manufacturing scale, not innovation, determines market access. For small-volume diagnostics, the bottleneck has shifted from product availability to supply chain reliability.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
|
|
No products in the cart.